AH

Abrahim Hussain

IN Inhibrx: 8 patents #7 of 23Top 35%
IB Inhibrx Biosciences: 2 patents #11 of 26Top 45%
Overall (All Time): #475,639 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12227584 Multivalent and multispecific OX40-binding fusion proteins Brendan P. Eckelman, John C. Timmer, Chelsie Macedo, Kyle S. Jones, Amir S. Razai +5 more 2025-02-18
12187804 Multivalent and multispecific 41BB-binding proteins Brendan P. Eckelman, John C. Timmer, Chelsie Macedo, Kyle S. Jones, Amir S. Razai +5 more 2025-01-07
11976126 Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cells John C. Timmer, Kyle S. Jones, Amir S. Razai, Katelyn M. Willis, Quinn Deveraux +1 more 2024-05-07
11566078 PDL1-binding proteins Brendan P. Eckelman, John C. Timmer, Chelsie Macedo, Kyle S. Jones, Amir S. Razai +5 more 2023-01-31
11117973 Multivalent and multispecific DR5-binding fusion proteins and methods of treating neoplasms John C. Timmer, Kyle S. Jones, Amir S. Razai, Katelyn M. Willis, Quinn Deveraux +1 more 2021-09-14
11117972 Multivalent and multispecific OX40-binding fusion proteins Brendan P. Eckelman, John C. Timmer, Chelsie Hata, Kyle S. Jones, Amir S. Razai +5 more 2021-09-14
10844129 Multivalent and multispecific glucocorticoid-induced TNFR-related protein (GITR)-binding single-domain antibody fusion proteins and encoding nucleic acids John C. Timmer, Kyle S. Jones, Amir S. Razai, Katelyn M. Willis, Quinn Deveraux +1 more 2020-11-24
10501551 Multivalent and multispecific 41BB-binding fusion proteins Brendan P. Eckelman, John C. Timmer, Chelsie Hata, Kyle S. Jones, Amir S. Razai +5 more 2019-12-10
10308720 Multivalent and multispecific DR5-binding fusion proteins John C. Timmer, Kyle S. Jones, Amir S. Razai, Katelyn M. Willis, Quinn Deveraux +1 more 2019-06-04
10093742 Multispecific GITR-binding fusion proteins and methods of use thereof John C. Timmer, Kyle S. Jones, Amir S. Razai, Katelyn M. Willis, Quinn Deveraux +1 more 2018-10-09